Table 2.
IMDC risk group classification.
| KARNOFSKY PS | <80% | |||
|---|---|---|---|---|
| Hemoglobin | <lower normal limit | |||
| Corrected serum calcium | >10 mg/dL | |||
| Period from diagnosis to treatment | <1 year | |||
| Neutrophil counts | >upper normal limit | |||
| Platelet count | >upper normal limit | |||
| Prognosis | Score | Median overall survival (months) | Survival at 2 years (%) | |
| Good | 0 | NR | 75 | |
| Intermediate | 1–2 | 27 mos. | 53 | |
| Poor | 3–6 | 8.8 mos. | 7 | |
IMDC, International Metastatic RCC Database Consortium.